|
Thank you for your interest in the commercial
application of Cleveland Clinic technology. Cleveland
Clinic is dedicated to transition its innovations into
widespread practice. CCI is the Cleveland Clinic's
technology commercialization arm with a mission to
"benefit the sick through the broad and rapid deployment
of Cleveland Clinic technology." CCI facilitates
innovation, creates spin-off companies, licenses technology,
secures resources and establishes strategic collaborations
with corporate partners.
Cleveland Clinic's long history of innovation
dates to its establishment in 1921. A founder of Cleveland
Clinic, George Crile, Sr., M.D., pioneered human-to-human
blood transfusion. In the 1950s, one of the world’s
first stopped-heart surgeries was performed here, using
a unique heart-lung machine. Cleveland Clinic cardiologist
Mason Sones, M.D., developed the process of moving cinecoronary
angiography, setting the stage for all of today's interventional
therapies for coronary artery disease. In 1967, Cleveland
Clinic surgeon Rene Favaloro, M.D., revolutionized cardiac
care when he performed the world’s first published
coronary artery bypass surgery.
Recent years have seen Cleveland Clinic
breakthroughs in heart valve repair, minimally invasive
cardiac surgery and the genetics of heart disease. This
year, Cleveland Clinic celebrates its 12th year in a
row ranked as America's #1 heart center in U.S. News
& World Report and is rated as one of the top four
hospitals.
Cleveland Clinic's heritage of innovation
expresses itself in many ways today - more than 150
new inventions per year, new interdisciplinary approaches
to diseases and path-breaking clinical insights that
help shape the standard of care.
Cleveland Clinic has entered a new phase
of technology commercialization. Nineteen spin-off companies
have been established in the last four years, most of
them with significant equity investment. Clinical trials
conducted at the Clinic have had a dramatic and growing
impact in the venture community. We have had a record
number of licenses.
If you are a company executive, investor,
entrepreneur or Cleveland Clinic staff member please
contact us (please see “contact
us” section).
Sincerely,
Christopher Coburn
Executive Director, CCF Innovations
|
